This literature review provides a comprehensive overview of osteoporosis, a prevalent bone condition affecting millions of older adults. The paper examines key risk factors including genetics, calcium deficiency, hormonal changes, and lifestyle habits; describes the body systems involved in primary and secondary osteoporosis; and outlines the serious complications that develop without treatment. The review synthesizes current medical evidence on treatment approaches, including calcium and vitamin D supplementation, pharmaceutical interventions such as bisphosphonates, and lifestyle modifications including weight-bearing exercise, smoking cessation, and fall prevention strategies.
Osteoporosis is a condition in which bones become weak and are prone to fracture (Ma, 2013). It is the most common bone disease affecting adults. Statistics show that approximately half of all women older than 50 will experience a fracture of the hip, wrist, or spine at some point in their lives. Normally, existing bone is replaced every 10 years through a process of bone remodeling. Osteoporosis develops when this replacement does not occur properly, or when the body reabsorbs too much existing bone, or both (Ma, 2013).
Multiple risk factors contribute to osteoporosis development. Primary risk factors include genetics, insufficient calcium intake, smoking, childhood or adult diseases, and reduced estrogen in women or testosterone in men (Ma, 2013). Osteoporosis can run in families, suggesting a hereditary component passed from parents to children.
Nutritional factors play a critical role. Lack of calcium is a major contributor to osteoporosis, as calcium is one of the most important minerals the body uses to form and maintain bone density. Vitamin D is equally important, as it enables calcium absorption. Without adequate levels of both nutrients, individuals become significantly more prone to fracture.
Additional risk factors include prolonged bed confinement, certain medical conditions and medications, long periods of absent menstruation, alcohol abuse, and low body weight (Ma, 2013). Lifestyle habits and hormonal status are therefore critical to prevention and management.
Osteoporosis is classified into two types: primary and secondary (Office of the Surgeon General, 2004). Primary osteoporosis affects the skeletal system along with the renal (kidney), reproductive, endocrine, and digestive systems. Secondary osteoporosis, which develops as a consequence of another disease or condition, involves the immune, nervous, and respiratory systems (Office of the Surgeon General, 2004).
This systemic involvement means that osteoporosis is not merely a localized bone problem but rather a condition affecting multiple organ systems and physiological processes throughout the body.
If osteoporosis is left untreated, it can progress to serious complications and secondary conditions (Office of the Surgeon General, 2004). Complications include rickets, osteomalacia, and renal osteodystrophy, as well as Paget's disease of the bones and osteogenesis imperfecta. Malignancy and cancer of the bones may develop, along with pathological fractures and progressive spinal deformity.
Additionally, untreated osteoporosis can lead to sex steroid deficiency, idiopathic hypercalciuria, complications related to cystic fibrosis, delayed puberty, amenorrhea, autoimmune and allergic disorders, and psychiatric and other nervous system disorders (Office of the Surgeon General, 2004). This progression underscores the importance of early detection and intervention.
Treatment of osteoporosis involves both pharmaceutical and nutritional interventions, along with lifestyle modification (Office of the Surgeon General, 2004; Ma, 2013). Calcium and vitamin D supplementation form the foundation of therapy, with medications designed to strengthen bone and slow bone loss.
Daily calcium intake recommendations are 1,200 mg for affected women and 1,000 mg for affected men. Medications prescribed include bisphosphonates for postmenopausal women, which slow bone resorption, as well as estrogen and estrogen receptor modulators for hormone replacement therapy. Other medications include teriparatide, which stimulates bone formation; calcitonin, used primarily for fracture pain management; and denosumab, a monoclonal antibody that inhibits bone loss (Office of the Surgeon General, 2004; Ma, 2013).
Lifestyle modification is essential to osteoporosis management, especially in older adults (Office of the Surgeon General, 2004). Exercise is a primary intervention, with emphasis on weight-bearing and resistance activities. Recommended weight-bearing exercises include walking, jogging, tennis, dancing, and rowing. Free-weight training and balance exercises are also recommended to strengthen muscles and prevent falls.
Other critical lifestyle changes include smoking cessation—either quitting if already smoking or never starting—and limiting alcohol consumption. Patients should avoid sedatives and other medications or conditions that increase fall risk, as fractures from falls are a major complication of osteoporosis. These modifications work synergistically with medical treatments to reduce fracture risk and maintain bone health throughout life.
Osteoporosis is a prevalent condition in which bones become prone to easy fracture (Office of the Surgeon General, 2004; Ma, 2013). Multiple risk factors contribute to its development, beginning with genetic predisposition and extending to dietary deficiencies in calcium and vitamin D. Many body systems become involved in the disease process, and without treatment, osteoporosis can progress to serious secondary conditions and complications.
"Synthesis of etiology, complications, and treatment approaches"
You’re 90% through this paper. Sign up to read the remaining 1 section.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.